NUMBRINO Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Numbrino patents expire, and when can generic versions of Numbrino launch?
Numbrino is a drug marketed by Cody Labs Inc and is included in one NDA.
The generic ingredient in NUMBRINO is cocaine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cocaine hydrochloride profile page.
Summary for NUMBRINO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NUMBRINO |
| What excipients (inactive ingredients) are in NUMBRINO? | NUMBRINO excipients list |
| DailyMed Link: | NUMBRINO at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NUMBRINO
US Patents and Regulatory Information for NUMBRINO
NUMBRINO is protected by zero US patents and two FDA Regulatory Exclusivities.
FDA Regulatory Exclusivity protecting NUMBRINO
NEW PRODUCT
Exclusivity Expiration: ⤷ Try a Trial
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cody Labs Inc | NUMBRINO | cocaine hydrochloride | SOLUTION;NASAL | 209575-001 | Jan 10, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cody Labs Inc | NUMBRINO | cocaine hydrochloride | SOLUTION;NASAL | 209575-001 | Jan 10, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
